Antimicrobial resistance (AMR) 

The overuse or misuse of antibiotics and other antimicrobials promotes the emergence of drug-resistant pathogens. Its devastating consequences undermine centuries of medical advancements, leading to prolonged and more difficult-to-treat diseases, increased treatment costs, and heightened risks in routine medical procedures.

A One Health approach to combat AMR

Since AMR is a global phenomenon affecting all living beings, addressing it requires a multidisciplinary approach. Embracing the One Health approach, the Mérieux Foundation initiates and participates in numerous collaborative surveillance projects to better understand its evolution and identify ways to slow it down. On the ground, we strengthen diagnostic laboratory capacities and connect them at national and international levels. By enabling them to conduct bacterial culture and antibiotic susceptibility tests, these laboratory networks improve patient care and generate essential data for AMR surveillance. We also provide training to clinicians on the appropriate use of antibiotics.

These initiatives enhance data collection and provide critical insights into the impact of national health policies. By strengthening the capacities of healthcare stakeholders and supporting countries in developing their action plans, we contribute to building more resilient healthcare systems against the AMR threat.